Iaso Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Zafrenszafrens.cominDec 2021
Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.
AI & Machine LearningBiotechDeep TechSan Diego, US
Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin
BoardJustin Briggsin
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.